UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
14A
Proxy
Statement Pursuant to Section 14(a) of the Securities
Exchange
Act of 1934 (Amendment No.
)
Filed by
the Registrant þ
Filed by
a Party other than the Registrant o
Check the
appropriate box:
o Preliminary Proxy
Statement
o Confidential, for
Use of the Commission Only (as permitted by Rule 14a- 6(e)(2) )
o Definitive Proxy
Statement
þ Definitive Additional
Materials
o Soliciting Material Pursuant to
§240.14a-12
Nektar
Therapeutics
(Name of
Registrant as Specified In Its Charter)
(Name
of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment
of Filing Fee (Check the appropriate box):
|
þ
|
No fee
required.
|
|
o
|
Fee computed on table below per
Exchange Act Rules 14a-6(i)(1) and
0-11.
|
|
(1)
|
Title of each class of securities
to which transaction applies:
|
|
|
(2)
|
Aggregate number of securities to
which transaction applies:
|
|
|
(3)
|
Per unit price or other
underlying value of transaction computed pursuant to Exchange Act
Rule 0-11 (set forth the amount on which the filing fee is calculated
and state how it was determined):
|
|
|
(4)
|
Proposed maximum aggregate value
of transaction:
|
|
|
(5)
|
Total fee
paid:
|
|
|
o
|
Fee paid previously with
preliminary materials.
|
|
o
|
Check box if any part of the fee
is offset as provided by Exchange Act Rule 0-11(a)(2) and identify
the filing for which the offsetting fee was paid previously. Identify the
previous filing by registration statement number, or the Form or Schedule
and the date of its filing.
|
|
(1)
|
Amount Previously
Paid:
|
|
(2)
|
Form, Schedule or Registration
Statement No.:
|
|
(3)
|
Filing
Party:
|
|
|
(4)
|
Date
Filed:
|
|
